Davion Healthcare PLC names Jack Kaye as Interim CEO following Glenn Williams' departure, signaling continued focus on growth in the medical instruments sector.
| Name | DAVION HEALTHCARE PLC |
|---|---|
| CIK | 0002039072 |
| Tickers | DAVI |
| Exchanges | Nasdaq |
| Entity type | other |
| Category | Non-accelerated filer<br>Emerging growth company |
| SIC | 3841 Surgical & Medical Instruments & Apparatus |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | G4 Cyprus |
| Phone | 357 25040052 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Davion Healthcare PLC names Jack Kaye as Interim CEO following Glenn Williams' departure, signaling continued focus on growth in the medical instruments sector.
Susan M. King, a director at Davion Healthcare, purchased 10,000 shares at $0.98 each, reflecting confidence in the company's future.
Davion Healthcare Plc offers guidance for shareholders on direct registration of shares amid short-selling concerns, enhancing ownership transparency.
Susan King, a board member of Davion Healthcare PLC, acquires 10,000 shares, raising her total holdings to 15,000 shares, reflecting confidence in the company.
Julian Sluyters, a director at Davion Healthcare PLC, acquires 25,000 shares, signaling confidence in the company's future.
Davion Healthcare PLC announces acquisition of Independence Care homecare network, expanding its U.S. operations with a $10 million deal.
Davion Healthcare PLC confirms 7.8 million shares registered under Cede & Co., reflecting strong shareholder engagement in the medical instruments sector.
Davion Healthcare PLC has appointed Vienna Capital Partners to assist in securing $100 million for acquisitions, targeting growth in the medical instruments sector.
Davion Healthcare PLC announces $13.5 million acquisition of Healthcare Stat Homecare Inc., expanding its presence in the home healthcare market.
Davion Healthcare has finalized a $25 million acquisition of Humaskan's medical technology IP, enhancing its product portfolio with innovative solutions.
Davion Healthcare PLC has filed a certification with the SEC, signaling important updates for the company and the surgical and medical instruments industry.
Davion Healthcare PLC reveals new executive leadership as it prepares for trading on Nasdaq, marking a pivotal moment for the company and the surgical instruments industry.
Davion Healthcare PLC announces Nasdaq trading debut and new executive team, aiming for growth in the medical instruments sector.
41 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 6-K | CURRENT REPORT | 0001683168-26-008991 | 001-42981 | 261579526 | 34 | 14272 | |||
| 2026-11-20 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001683168-26-008975 | 005-95618 | 261576736 | 34 | 11939 | |||
| 2026-11-20 | 4 | xslF345X06/ownership.xml | 0001683168-26-008973 | 9976 | ||||||
| 2026-11-18 | 4/A | xslF345X06/ownership.xml | 0001683168-26-008919 | 4963 | ||||||
| 2026-11-17 | 6-K | FORM 6-K | 0001683168-26-008905 | 001-42981 | 261565638 | 34 | 38512 | |||
| 2026-11-17 | 4 | xslF345X06/ownership.xml | 0001683168-26-008903 | 4887 | ||||||
| 2026-11-17 | 4 | xslF345X06/ownership.xml | 0001683168-26-008890 | 4873 | ||||||
| 2026-11-16 | 6-K | CURRENT REPORT | 0001683168-26-008791 | 001-42981 | 261557005 | 34 | 40211 | |||
| 2026-11-09 | 6-K | FORM 6-K | 0001683168-26-008431 | 001-42981 | 261535344 | 34 | 13041 | |||
| 2026-11-09 | 6-K | CURRENT REPORT OF FOREIGN ISSUER | 0001683168-26-008401 | 001-42981 | 261533843 | 34 | 30523 | |||
| 2026-10-29 | 6-K | FORM 6-K | 0001683168-26-008146 | 001-42981 | 261497694 | 34 | 29743 | |||
| 2026-10-27 | 6-K | FORM 6-K | 0001683168-26-008102 | 001-42981 | 261487392 | 34 | 38725 | |||
| 2026-10-21 | CERT | DAVI_8A_Cert_0002039072.pdf | 0001354457-26-001010 | 001-42981 | 261475542 | 34 | 180852 | |||
| 2026-10-20 | 424B3 | PROSPECTUS | 0001683168-26-007978 | 333-289205 | 261471002 | 33 | 14705 | |||
| 2026-10-20 | 6-K | CURRENT REPORT | 0001683168-26-007973 | 001-42981 | 261470751 | 34 | 45490 | |||
| 2026-10-13 | 424B3 | FORM 424B3 | 0001683168-26-007775 | 333-289205 | 261455004 | 33 | 7758 | |||
| 2026-09-15 | 6-K | FORM 6-K | 0001683168-26-007122 | 001-42981 | 261379178 | 34 | 36149 | |||
| 2026-09-08 | D | xslFormDX01/primary_doc.xml | 06b | 0001683168-26-006990 | 021-596585 | 261363449 | 33 | 7081 | ||
| 2026-09-02 | POS AM | POS AM | 0001683168-26-006890 | 333-289205 | 261355383 | 33 | 5134764 | 1 | 1 | |
| 2026-08-17 | POS AM | POST EFFECTIVE AMENDMENT NO. 6 | 0001683168-26-006527 | 333-289205 | 261286543 | 33 | 5159091 | 1 | 1 | |
| 2026-08-11 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001683168-26-006175 | 005-95618 | 261260660 | 34 | 19020 | |||
| 2026-05-06 | 20-F/A | FORM 20-F FOR DEC 2025 AMENDMENT 1 | 0001683168-26-003530 | 001-42981 | 26947601 | 34 | 4681645 | 1 | 1 | |
| 2026-05-01 | POS AM | POST-EFFECTIVE AMENDMENT #5 | 0001683168-26-003414 | 333-289205 | 26931550 | 33 | 4903630 | 1 | 1 | |
| 2026-04-30 | 20-F | FORM 20-F FOR DEC 2025 | 0001683168-26-003389 | 001-42981 | 26927356 | 34 | 4666475 | 1 | 1 | |
| 2026-04-17 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001683168-26-003031 | 005-95618 | 26870152 | 34 | 13778 | |||
| 2026-04-17 | 3 | xslF345X06/ownership.xml | 0001683168-26-003030 | 5825 | ||||||
| 2026-04-06 | POS AM | AMENDMENT NO. 4 | 0001683168-26-002675 | 333-289205 | 26839842 | 33 | 6146859 | 1 | 1 | |
| 2026-03-04 | POS AM | POST EFFECTIVE AMENDMENT NO. 3 | 0001683168-26-001483 | 333-289205 | 26721648 | 33 | 20713560 | 1 | 1 | |
| 2026-02-04 | POS AM | POS AM NO. 2 | 0001683168-26-000755 | 333-289205 | 26599153 | 33 | 20677127 | 1 | 1 | |
| 2026-01-05 | 6-K | FORM 6-K | 0001683168-26-000062 | 001-42981 | 26503961 | 34 | 36448 | |||
| 2025-12-09 | POS AM | AMENDMENT NO 1 | 0001683168-25-009004 | 333-289205 | 251557956 | 33 | 3714216 | 1 | 1 | |
| 2025-12-08 | AW | FORM AW | 0001683168-25-008974 | 333-289205 | 251555268 | NE | 6669 | |||
| 2025-12-05 | F-1/A | AMENDMENT NO. 3 TO FORM F-1 | 0001683168-25-008911 | 333-289205 | 251551490 | 33 | 3715683 | 1 | 1 | |
| 2025-12-02 | 6-K | FORM 6-K | 0001683168-25-008786 | 001-42981 | 251541707 | 34 | 18513 | |||
| 2025-11-28 | 8-A12B | FORM 8-A12B | 0001683168-25-008714 | 001-42981 | 251532502 | 34 | 16971 | |||
| 2025-11-07 | F-1/A | AMENDMENT NO. 2 TO FORM F-1 | 0001683168-25-008066 | 333-289205 | 251462385 | 33 | 4258737 | 1 | 1 | |
| 2025-10-20 | CORRESP | filename1.htm | 0001683168-25-007659 | 13371 | ||||||
| 2025-09-26 | CORRESP | filename1.htm | 0001683168-25-007262 | 128565 | ||||||
| 2025-09-26 | F-1/A | AMENDMENT TO F-1 | 0001683168-25-007261 | 333-289205 | 251350489 | 33 | 4065316 | 1 | 1 | |
| 2025-09-01 | UPLOAD | filename1.pdf | 0000000000-25-009403 | 333-289205 | 97896 | |||||
| 2025-08-04 | F-1 | FORM F-1 | 0001683168-25-005601 | 333-289205 | 251178387 | 33 | 4009512 | 1 | 1 |
One latest value per concept from companyfacts (3 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 25.00M | 2025-12-31 | 2025 | FY | 20-F/A | 2026-05-06 | 0001683168-26-003530 | |
| dei | EntityNumberOfEmployees | Entity Number of Employees | Decimal | 0 | 2025-12-31 | 2024 | FY | POS AM | 2026-09-02 | 0001683168-26-006890 | |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Number | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F/A | 2026-05-06 | 0001683168-26-003530 |